Biomarkers For Enhanced Vaccine Safety (BioVacSafe)

On March 1st 2012 the IMI-JU funded project – Biomarkers for Enhanced Vaccine Safety (BioVacSafe) – initiated its collaborative work to develop new tools that will improve the evaluation and monitoring of vaccine immunosafety. BioVacSafe is a public private consortium of 19 partners involving three of Europe's leading vaccine producing companies, experts from major academic institutions, small and medium-sized enterprises (SMEs) and non-governmental organization (NGO) actors. The total budget of the project is 30.2 millions of Euros and it will last for five years. BioVacSafe aims at establishing tools, methods and guidelines for the evaluation of vaccine reactogenicity and enhancing immunosafety of novel vaccines. In that context, BioVacSafe partners have a unique opportunity to tackle the urgent need to establish new ways of collaboration among industry, academia, biotech companies, regulators and patients' organizations to promote and support R&D for safer vaccines

Partner organizations

  • Utrecht University (Academic, Netherlands)
  • Statens Serum Institut (Public, Denmark)
  • University of Surrey (Academic, United Kingdom)
  • Charité University Medicine Berlin (Academic, Germany)
  • Sanofi Pasteur (Private, France)
  • St George's Univerity of London (Academic, United Kingdom)
  • University of Siena (Academic, Italy)
  • GlaxoSmithKline Biologicals - Belgium (Private, Belgium)
  • The French Alternative Energies and Atomic Energy Commission (CEA) (Research Institute, France)
  • CDISC European Foundation (Non Profit, Belgium)
  • VisMederi (Private, Italy)
  • Novartis Vaccines & Diagnostics (Private, Italy)
  • Department Of Health (Public, United Kingdom)
  • University of Gothenburg (Academic, Sweden)
  • University of Gothenburg (Publisher, Sweden)
  • ImmunArray (Private, Israel)
  • Imperial College London (Academic, United Kingdom)
  • Ghent university (Academic, Belgium)
  • Max Planck Institute (Research Institute, Germany)
Start date 01/03/2012
End date The project is closed: 28/02/2017

Published: Sat 16 Nov 2019.